Drug & Medication

Summary

Table of Contents

  • Publication date: February 2009
Keywords : Drug , chemotherapeutic , Estrogen, Progesterone, Paclitaxel

China's demand for Breast Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 a...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Robyn

00 1 718 213 49 04

Send Your Request

Share

Drug And Medication Industry in China : Latest Reports

Chinese Markets for Hepatitis Drugs

Chinese Markets for Hepatitis Drugs

  • $ 4 000
  • Industry report
  • April 2012
  • by Asia Market Information & Development Company

China's demand for hepatitis drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, ...

Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)

Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)

  • $ 2 395
  • Industry report
  • January 2012
  • by Transparency Market Research

In 2009, the global Osteoporosis drug market was worth USD 6.8 billion, with Bisphosphonate class of drugs leading the market. In the overall Bisphosphonate, ibandronate (Bonviva/Boniva; Roche) and zoledronate ...

Leading Asia-Pacific Drugs, Health and Beauty Retailers - Company Benchmarking Analysis Report

Leading Asia-Pacific Drugs, Health and Beauty Retailers - Company Benchmarking Analysis Report

  • $ 1 950
  • Industry report
  • February 2012
  • by Canadean Ltd

Synopsis This report contains a competitive company benchmarking analysis based on key financial and operating parameters and ratios of a select peer group of companies, compared to one another and to ...

Orphan Drugs In Asia 2012

April 2012 $ 1 500

The Pharmaceutical Market: China

February 2012 $ 1 085

The Cmo Market Outlook To 2017

February 2012 $ 3 835

Drug And Medication Industry in China : Latest Downloads

The Chinese Drug and Medication Business : Innovation and Technology Trends

The Chinese Drug and Medication Business : Innovation and Technology Trends

  • Industry report
  • May 2012
  • 4 pages

... medicines, antibiotics, biochemical drugs and biological products (1) represents the premium / (discount) between offer price and closing price one day prior to pricing source: company announcements ...

Drug and Medication in China : Innovation and Technology Trends

Drug and Medication in China : Innovation and Technology Trends

  • Industry report
  • March 2012
  • 30 pages
  • by Corporation

... As gilead S fda-approved viread but activated by a different molecular sidechain. tenofovir df (viread) is fda approved in usa for hiv (2001) and hbv (2008). It is not reveal study The relationship ...

The Chinese Drug and Medication Business Brief

The Chinese Drug and Medication Business Brief

  • Industry report
  • January 2012
  • 12 pages
  • by Intergovernmental Agency


Related Market Segments :

Hormone
Cancer Drug
Drug
Chemotherapeutic
Estrogen

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.